WASHINGTON, April 27 /PRNewswire-USNewswire/ -- Lung Cancer Alliance announced that a comprehensive lung cancer research funding bill targeting lung cancer's high mortality rate was introduced with bipartisan support today in the U.S. House of Representatives today.
"We now have legislation authorizing a broad new comprehensive, multi-agency approach to lung cancer in both Houses of Congress. This is a milestone -- the turning point we are all looking for in federal policy on lung cancer," said LCA President and CEO Laurie Fenton Ambrose.
"We are deeply grateful to the bill's primary sponsors, Congresswoman Donna M. Christensen (D-VI) and Congressman Frank A. LoBiondo (R-NJ), for their continuing leadership on this issue," she said.
Congresswomen Christensen, now in her seventh term, is the first female doctor ever elected to the House of Representatives, a member of the powerful Energy and Commerce Committee which has jurisdiction over health policy and chair of the Congressional Black Caucus Health Braintrust.
"The toll of lung cancer is enormous. It is the biggest cancer killer in every ethnic group, taking more lives each year than the next four most common cancers combined," Congresswoman Christensen said. "With over 60% of new cases being diagnosed in people who never smoked or who had already quit, we need to address this disease as a priority with a more comprehensive strategy."
Congressman LoBiondo, in his eighth term, has been a key legislator on transportation, national security and environmental issues.
"There has been some progress in developing treatments and reducing mortality in lung cancer, but much
|SOURCE Lung Cancer Alliance|
Copyright©2009 PR Newswire.
All rights reserved